| Bioactivity | Ulefnersen is a RNA-binding protein fused-in sarcoma (FUS) synthesis reducer[1]. Ulefnersen can be used in Amyotrophic Lateral Sclerosis (ALS) research[2]. |
| Name | Ulefnersen |
| CAS | 2589926-25-8 |
| Formula | C230H321N68O126P19S13 |
| Molar Mass | 7059.72 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. https://cdn.who.int/media/docs/default-source/international-nonproprietary-names-(inn)/pl127.pdf?sfvrsn=8544ca1e_3&download=true [2]. https://chem.nlm.nih.gov/chemidplus/name/ulefnersen%20sodium |
Ulefnersen
CAS: 2589926-25-8 F: C230H321N68O126P19S13 W: 7059.72
Ulefnersen is a RNA-binding protein fused-in sarcoma (FUS) synthesis reducer. Ulefnersen can be used in Amyotrophic Late
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.